Efficacy and safety of UCB-derived or autologous CIK cells combined with interferon therapy in patients with chronic hepatitis B

ObjectiveTo investigate the efficacy and safety of umbilical cord blood (UCB)-derived or autologous cytokine-induced killer (CIK) cells combined with interferon therapy in patients with chronic hepatitis B (CHB). MethodsThirty CHB patients hospitalized in the Department of Infectious Diseases from O...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autor: LIU Bo
Médium: Artigo
Jazyk:Chinês
Vydáno: Editorial Department of Journal of Clinical Hepatology 2014-09-01
Edice:Linchuang Gandanbing Zazhi
Témata:
hepatitis B
chronic; killer cells; interferon type Ⅱ
On-line přístup:http://www.lcgdbzz.org/qk_content.asp?id=6003&ClassID=86133151
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky